APC and malignant colon neoplasm: In colon cancer, oncogenic mutations that inactivate Apc are tenfold more prevalent than oncogenic mutations in other Wnt pathway regulatory components, suggesting that functions other than Wnt pathway deregulation contribute to disease aetiology.